Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. European Medicines Agency. New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection [media release]. 16 Sep 2022. https://www.ema.europa.eu/en/news/new-medicine-protect-babies-infants-respiratory-syncytial-virus-rsv-infection.
2. Esposito S, Abu Raya B, Baraldi E, et al. RSV prevention in all Infants: which is the most preferable strategy? Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.880368.
3. National Center for Immunization and Respiratory Diseases (NCIRD) Division of Viral Diseases. RSV in infants and young children. 2020. https://www.cdc.gov/rsv/high-risk/infants-young-children.html. Accessed 20 Sep 2022.
4. Shi T, McAllister DA, O’Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946–58.
5. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588–98.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献